SB
Singh Biotechnology
Singh Biotechnology develops single-domain antibodies that target intracellular proteins to treat diseases. Their technology platform enables targeted therapies for cancers, autoimmune disorders, and ophthalmologic conditions. The company's focus is on creating novel treatments by accessing previously undruggable intracellular targets.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Singh Biotechnology develops single-domain antibodies that target intracellular proteins to treat diseases. Their technology platform enables targeted therapies for cancers, autoimmune disorders, and ophthalmologic conditions. The company's focus is on creating novel treatments by accessing previously undruggable intracellular targets.